Microlyte® Matrix

Partial and full-thickness chronic wounds including:

• Pressure ulcers
• Venous statis ulcers
• Diabetic foot ulcers

Surgical wounds including:

• Donor sites
• Use over debrided and grafted partial thickness wounds
• Post Moh’s surgery
• Post laser surgery
• Podiatry
• Dehisced wounds

Traumatic wounds including:

• First and second-degree burns
• Abrasions
• Lacerations
• Skin tears

Debridement and removal of necrotic tissue is recommended before matrix placement.

Published clinical data in the November 2020 edition of WOUNDS journal shows the clinical results of using Microlyte® for chronic wounds. Thirty-two patients with various chronic wounds were evaluated. All wounds were non-healing for a median of 39 weeks (range, 3-137 weeks).

• At 3 weeks: 79% closure in responsive DFU patients. 60% closure in responsive venous stasis ulcers. 72% of all wounds had significantly improved healing with an average wound area reduction of 66%.
• At 12 weeks: 91% of wounds either healed completely or improved significantly with an average wound area reduction of 73%.

The application of Microlyte® was safe and well tolerated, and it facilitated improvements in healing of a majority of the complex chronic wounds studied.